Profit-Sharing AI Model Proposed To Boost Korean Drug R&D

Rewards For Sharing Personal Data

A differentiated profit-sharing model to accelerate the use of AI in drug development using clinical and patient data is being proposed in South Korea, but the idea faces multiple practical challenges

AI, Big Data, Drug Development and South Korea
Korea Has To Find Its Own Breakthrough In AI New Drug Development (Shutterstock/AI generated image)

As artificial intelligence (AI) and the biopharma industry are key sectors that look set to be fostered by the administration of South Korea’s new president, companies in the country are expected to accelerate moves to adopt AI technologies related to drug discovery and development.

But being a relative latecomer in the area, Korea may need an innovative strategy not seen elsewhere if it is...

More from AI

More from R&D